{"name":"Thiamylal","slug":"thiamylal","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Thioseconal","5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid","4,6(1H,5H)-Pyrimidinedione, dihydro-5-(1-methylbutyl)-5-(2-propenyl)-2-thioxo-","dihydro-5-(1-methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione","5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione","5-allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione","5-(pentan-2-yl)-5-(prop-2-en-1-yl)-2-sulfanylidene-1,3-diazinane-4,6-dione","Thioquinalbarbitone","4,6-dihydroxy-5-(pentan-2-yl)-5-(prop-2-en-1-yl)-2,5-dihydropyrimidine-2-thione","201-018-3"],"brands":[],"scraped":true,"has_structure":true,"cid":3032285,"classes":[],"families":[{"name":"thiobarbiturate","href":"/substituted/thiobarbiturate"}],"physical":[{"label":"Molecular mass","value":"254.35 g/mol","copyable":false},{"label":"Melting point","value":"132-133 °C","copyable":false},{"label":"Solubility","value":"49.4 mg/L (at 25 °C)","copyable":false},{"label":"Predicted LogP","value":"3.2","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>12</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>S","copyable":true},{"label":"IUPAC name","value":"5-pentan-2-yl-5-prop-2-enyl-2-sulfanylidene-1,3-diazinane-4,6-dione","copyable":true},{"label":"SMILES","value":"CCCC(C)C1(C(=O)NC(=S)NC1=O)CC=C","copyable":true},{"label":"InChI","value":"InChI=1S/C12H18N2O2S/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)","copyable":true},{"label":"InChIKey","value":"XLOMZPUITCYLMJ-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"77-27-0","copyable":true},{"label":"UNII","value":"01T23W89FR","copyable":true},{"label":"PubChem CID","value":"3032285","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"14.3 h (cats)","copyable":false},{"label":"Metabolism","value":"Hepatic","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[],"mesh":[{"name":"Hypnotics and Sedatives","id":"M0010885"},{"name":"Anesthetics, Intravenous","id":"M0027999"},{"name":"GABA Modulators","id":"M0028093"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"GABRA1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA4","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA5","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRA6","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRB3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRD","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRE","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG1","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG2","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRG3","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRP","mechanisms":["shared target"],"partners":32,"contraindicated":0},{"target":"GABRQ","mechanisms":["shared target"],"partners":32,"contraindicated":0}],"mechanism":"Thiamylal binds at a distinct binding site associated with a Cl<sup>-</sup> ionopore at the GABA<sub>A</sub> receptor, increasing the duration of time for which the Cl<sup>-</sup> ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged.","side_effects":null,"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"B1","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"United States","status":"Schedule III","act":"Controlled Substances Act","refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Thiamylal"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/3032285"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q906102"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01154"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL440"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A9536"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=77-27-0"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0015285"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D06106"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID3048441"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Thiamylal"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/01T23W89FR"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 3032285, Thiamylal. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/3032285>https://pubchem.ncbi.nlm.nih.gov/compound/3032285</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Thiamylal. UNII: 01T23W89FR. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/01T23W89FR>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/01T23W89FR</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 15:52:53","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 15:52:49","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 15:52:49","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 15:52:50","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 15:52:49","note":"hmdb.ca refused automated access to HMDB0015285"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 15:52:51","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 15:52:48","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 15:52:49","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 15:52:49","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 15:52:49","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 15:52:49","note":null}],"description":"Thiamylal is a  substance."}